10
-
$18 million for transplant and gene-editing research
The California Institute for Regenerative Medicine has funded Stanford Medicine projects to improve kidney transplantation and advance treatment for a rare genetic disease in children.
-
New way to treat COVID-19 smell loss
In a trial led by Stanford Medicine researchers, more than half of patients with persistent smell loss saw improvement with injections of platelet-rich plasma.
-
Stanford and Invus collaborate
The collaboration will enable the development of medications to treat a type of brain cancer.
-
Autism hinders grasp of vocal emotion
Children with autism have trouble identifying emotional tones because of differences in a brain region that processes social information, a Stanford Medicine study found.
-
How COVID-19 virus infects nasal cells
A discovery by Stanford Medicine researchers and colleagues may pave the way for a “morning after” or prophylactic nasal spray to prevent infection.
-
Blood test identifies infections
A diagnostic test developed by Stanford Medicine scientists can separate bacterial and viral infections with 90% accuracy, the first to meet standards set by the World Health Organization.
-
Shoshana Levy dies
Shoshana Levy discovered a family of molecules called tetraspanins, launching a new field of cancer research. She was an active researcher, collaborator and mentor at Stanford Medicine for nearly three decades.
-
Translational research master’s program
A new Stanford School of Medicine master’s program trains students in taking basic science research findings from the lab to patient care.
-
Gel treatment heals blistering wounds
Researchers find that a gel tested in patients with a life-threatening blistering skin disease helps wounds heal. The gel — the first topical gene therapy — awaits FDA approval.
-
Possible new way to kill cancer cells
After finding long, repetitive sequences in the genomes of seven kinds of cancer, researchers at Stanford Medicine and their colleagues developed a molecule that curbed their production.